论文部分内容阅读
目的:研究探索孟鲁司特钠联合布地奈德治疗小儿支气管哮喘的临床使用效果。方法:选取我院54例患支气管哮喘且在急性发作期的小儿患者,分为实验组、对照组A和对照组B,予以不同的治疗方法,其中实验组使用孟鲁司特钠联合布地奈德,对照组A只使用孟鲁司特钠,对照组B只使用布地奈德,将治疗效果进行分析总结。结果:实验组中有效率为94.4%,对照组A与对照组B的有效率均为77.8%。实验组的治疗效果明显比对照组A和对照组B的治疗效果好很多。结论:孟鲁司特钠联合布地奈德能有效改善支气管哮喘的儿童患者的症状和体征,治疗效果良好,在临床应用上值得广泛推广。
Objective: To explore the clinical efficacy of montelukast combined with budesonide in the treatment of pediatric bronchial asthma. Methods: 54 pediatric patients with bronchial asthma and acute exacerbation were enrolled in this study. They were divided into experimental group, control group A and control group B, and were given different treatment methods. The experimental group used montelukast sodium combined with budesonide Germany, the control group A only montelukast sodium, the control group B only budesonide, the treatment effect analysis and summary. Results: The effective rate was 94.4% in the experimental group and 77.8% in the control group A and the control group B. The treatment effect of the experimental group was significantly better than that of the control group A and the control group B. Conclusion: Combination of montelukast and budesonide can effectively improve the symptoms and signs of children with bronchial asthma. The treatment effect is good and it is widely used in clinical application.